Tech Company Financing Transactions
Adenocyte Funding Round
Adenocyte secured a funding round on 5/26/2026. Backers included iGan Partners.
Transaction Overview
Company Name
Announced On
5/26/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for clinical and commercial expansion and continued technical development of its proprietary LINFU platform for cytological sampling of the pancreas, breast, and prostate.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Ha-Marpe St 8, Har Hotzvim
Jerusalem, 9777408
Israel
Jerusalem, 9777408
Israel
Phone
Undisclosed
Website
Email Address
Overview
Our team comprised of ultrasound biomedical engineers and cytopathologists. The scientific and medical staff of Adenocyte represents a nexus of world renowned expertise in cytopathology, medical ultrasound, biomedical engineering, molecular cancer cell biology, gastroenterology, and pancreatic surgery. Our laboratories are located in Haifa and Jerusalem Israel, with clinical development and testing performed at the Technion -- Israel Institute of Technology, and at North American pancreatic cancer screening centers.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/26/2026: Human Archive venture capital transaction
Next: 5/26/2026: GEEIQ venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








